Melatonin as a potential inhibitory agent in head and neck cancer

Chia Ming Yeh, Shih Chi Su, Chiao Wen Lin, Wei En Yang, Ming Hsien Chien, Russel J. Reiter, Shun Fa Yang

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Melatonin is a molecule secreted by the pineal gland; it is an important regulator of sleep and circadian rhythms. Through multiple interrelated mechanisms, melatonin exhibits various inhibitory properties at different stages of tumor progression. Many studies have explored the oncostatic effects of melatonin on hormone-dependent tumors. In this review, we highlight recent advances in understanding the effects of melatonin on the development of head and neck cancers, including molecular mechanisms identified through experimental and clinical observations. Because melatonin exerts a wide range of effects, melatonin may influence many mechanisms that influence the development of cancer. These include cell proliferation, apoptosis, angiogenesis, extracellular matrix remodeling through matrix metalloproteinases, and genetic polymorphism. Thus, the evidence discussed in this article will serve as a basis for basic and clinical research to promote the use of melatonin for understanding and controlling the development of head and neck cancers.

Original languageEnglish
Pages (from-to)90545-90556
Number of pages12
JournalOncotarget
Volume8
Issue number52
DOIs
Publication statusPublished - 2017

Fingerprint

Melatonin
Head and Neck Neoplasms
Neoplasms
Pineal Gland
Genetic Polymorphisms
Circadian Rhythm
Matrix Metalloproteinases
Extracellular Matrix
Sleep
Cell Proliferation
Hormones
Apoptosis
Research

Keywords

  • Head and neck cancers
  • Matrix metalloproteinase
  • Melatonin
  • Metastasis

ASJC Scopus subject areas

  • Oncology

Cite this

Yeh, C. M., Su, S. C., Lin, C. W., Yang, W. E., Chien, M. H., Reiter, R. J., & Yang, S. F. (2017). Melatonin as a potential inhibitory agent in head and neck cancer. Oncotarget, 8(52), 90545-90556. https://doi.org/10.18632/oncotarget.20079

Melatonin as a potential inhibitory agent in head and neck cancer. / Yeh, Chia Ming; Su, Shih Chi; Lin, Chiao Wen; Yang, Wei En; Chien, Ming Hsien; Reiter, Russel J.; Yang, Shun Fa.

In: Oncotarget, Vol. 8, No. 52, 2017, p. 90545-90556.

Research output: Contribution to journalReview article

Yeh, CM, Su, SC, Lin, CW, Yang, WE, Chien, MH, Reiter, RJ & Yang, SF 2017, 'Melatonin as a potential inhibitory agent in head and neck cancer', Oncotarget, vol. 8, no. 52, pp. 90545-90556. https://doi.org/10.18632/oncotarget.20079
Yeh, Chia Ming ; Su, Shih Chi ; Lin, Chiao Wen ; Yang, Wei En ; Chien, Ming Hsien ; Reiter, Russel J. ; Yang, Shun Fa. / Melatonin as a potential inhibitory agent in head and neck cancer. In: Oncotarget. 2017 ; Vol. 8, No. 52. pp. 90545-90556.
@article{08cf16f2e5bf4856a75e1fecbafdee73,
title = "Melatonin as a potential inhibitory agent in head and neck cancer",
abstract = "Melatonin is a molecule secreted by the pineal gland; it is an important regulator of sleep and circadian rhythms. Through multiple interrelated mechanisms, melatonin exhibits various inhibitory properties at different stages of tumor progression. Many studies have explored the oncostatic effects of melatonin on hormone-dependent tumors. In this review, we highlight recent advances in understanding the effects of melatonin on the development of head and neck cancers, including molecular mechanisms identified through experimental and clinical observations. Because melatonin exerts a wide range of effects, melatonin may influence many mechanisms that influence the development of cancer. These include cell proliferation, apoptosis, angiogenesis, extracellular matrix remodeling through matrix metalloproteinases, and genetic polymorphism. Thus, the evidence discussed in this article will serve as a basis for basic and clinical research to promote the use of melatonin for understanding and controlling the development of head and neck cancers.",
keywords = "Head and neck cancers, Matrix metalloproteinase, Melatonin, Metastasis",
author = "Yeh, {Chia Ming} and Su, {Shih Chi} and Lin, {Chiao Wen} and Yang, {Wei En} and Chien, {Ming Hsien} and Reiter, {Russel J.} and Yang, {Shun Fa}",
year = "2017",
doi = "10.18632/oncotarget.20079",
language = "English",
volume = "8",
pages = "90545--90556",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "52",

}

TY - JOUR

T1 - Melatonin as a potential inhibitory agent in head and neck cancer

AU - Yeh, Chia Ming

AU - Su, Shih Chi

AU - Lin, Chiao Wen

AU - Yang, Wei En

AU - Chien, Ming Hsien

AU - Reiter, Russel J.

AU - Yang, Shun Fa

PY - 2017

Y1 - 2017

N2 - Melatonin is a molecule secreted by the pineal gland; it is an important regulator of sleep and circadian rhythms. Through multiple interrelated mechanisms, melatonin exhibits various inhibitory properties at different stages of tumor progression. Many studies have explored the oncostatic effects of melatonin on hormone-dependent tumors. In this review, we highlight recent advances in understanding the effects of melatonin on the development of head and neck cancers, including molecular mechanisms identified through experimental and clinical observations. Because melatonin exerts a wide range of effects, melatonin may influence many mechanisms that influence the development of cancer. These include cell proliferation, apoptosis, angiogenesis, extracellular matrix remodeling through matrix metalloproteinases, and genetic polymorphism. Thus, the evidence discussed in this article will serve as a basis for basic and clinical research to promote the use of melatonin for understanding and controlling the development of head and neck cancers.

AB - Melatonin is a molecule secreted by the pineal gland; it is an important regulator of sleep and circadian rhythms. Through multiple interrelated mechanisms, melatonin exhibits various inhibitory properties at different stages of tumor progression. Many studies have explored the oncostatic effects of melatonin on hormone-dependent tumors. In this review, we highlight recent advances in understanding the effects of melatonin on the development of head and neck cancers, including molecular mechanisms identified through experimental and clinical observations. Because melatonin exerts a wide range of effects, melatonin may influence many mechanisms that influence the development of cancer. These include cell proliferation, apoptosis, angiogenesis, extracellular matrix remodeling through matrix metalloproteinases, and genetic polymorphism. Thus, the evidence discussed in this article will serve as a basis for basic and clinical research to promote the use of melatonin for understanding and controlling the development of head and neck cancers.

KW - Head and neck cancers

KW - Matrix metalloproteinase

KW - Melatonin

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=85032268982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032268982&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.20079

DO - 10.18632/oncotarget.20079

M3 - Review article

AN - SCOPUS:85032268982

VL - 8

SP - 90545

EP - 90556

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 52

ER -